Scinai Immunotherapeutics (SCNI) Depreciation & Amortization (CF) (2019 - 2024)

Scinai Immunotherapeutics has disclosed Depreciation & Amortization (CF) across 6 years of filings, most recently posting $499000.0 for Q4 2024.

• Depreciation & Amortization (CF) for Q4 2024 came in at $499000.0, up 494.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $997000.0 (down 39.54% YoY), and the FY2025 annual result was $1.4 million, down 13.83% from the prior year.
• Depreciation & Amortization (CF) came in at $499000.0 for Q4 2024 at Scinai Immunotherapeutics, roughly flat from $498000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $626000.0 in Q3 2020 to a low of -$93000.0 in Q4 2021.
• The 5-year median for Depreciation & Amortization (CF) is $181000.0 (2021), against an average of $308631.6.
• Across the five-year window, Depreciation & Amortization (CF) sank 115.35% in 2021 and jumped 494.05% in 2024, its largest moves.
• Scinai Immunotherapeutics' Depreciation & Amortization (CF) stood at $606000.0 in 2020, then sank by 115.35% to -$93000.0 in 2021, then surged by 297.85% to $184000.0 in 2022, then tumbled by 54.35% to $84000.0 in 2023, then surged by 494.05% to $499000.0 in 2024.
• The last three Depreciation & Amortization (CF) figures came in at $499000.0 (Q4 2024), $498000.0 (Q3 2024), and $496000.0 (Q2 2024), per Business Quant data.